Avanir Pharmaceuticals Up Following No Recent News

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) was up $0.11 (4.12%) this morning to $2.78.

Avanir Pharmaceuticals, Inc. is a biopharm company that specializes in the development and commercialization of therapeutic products primarily for the treatment of central nervous system disorders.  The company’s main products include Zenviatm, used for the treatment of pseudobulbar affect and diabetic peripheral neuropathic pain, and Abreva, an over-the-counter product used for the treatment of cold sores.

Comments

BioHealth Investor RSS Feed

• 

• Recent Posts

  • Shouldn’t VIVUS Raise Capital Now? (VVUS)
  • Can Human Genome Really Double Its Stock Price? (HGSI)
  • Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
  • Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
  • Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)

• Archives

  • February 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

• Categories

  • Acquisitions
  • alzheimer's
  • analyst calls
  • Anemia
  • Atherosclerosis
  • blogfile
  • Cancer
  • Cardiac
  • Contraceptives
  • daily
  • dendreon
  • Depression
  • Devices
  • Diabetes
  • Diagnostics
  • Epilepsy
  • erectile dysfunction
  • fda
  • fibromyalgia
  • Financial
  • flu
  • General
  • generic drugs
  • genomics
  • Heart
  • Hepatitis C
  • HIV
  • Infections
  • IPO
  • Lung
  • Lupus
  • M&A
  • Medicare
  • Meningitis
  • merck
  • mesothelioma
  • MRSA
  • multiple sclerosis
  • obesity
  • Options
  • osteoporosis
  • Pain
  • papilloma virus
  • politics
  • psoriasis
  • R&D
  • Research
  • rheumatoid arthritis
  • Rumor
  • Secondary Offering
  • shingles
  • Sleep Disorder
  • stem cells
  • targacept
  • Uncategorized
  • vaccine

• Latest from 247Wallst.com

  • Shareholders Shouldn’t ‘Like’ Zuckerberg’s Wedding (FB)
  • Merkel Will Turn Her Back On G8
  • Alibaba To Buy $7 Billion Stake From Yahoo!
  • Sprint Offers AT&T And Verizon Customers $100 iPhone Trade In
  • Google’s YouTube: The One Horse Race In Online Video

• Latest from VSInvestor

  • Huge Volume Spike in LED Stocks: It Looks Real This Time (CREE, VECO, AIXG)
  • Chart Damage in Apple on Above-Average Volume (AAPL)
  • Sizing Up Express-1 (XPO, URI)
  • Odds-Making: Is Brocade Really Bait For Dell? (BRCD, DELL, CSCO, HPQ)
  • Volume Spike Analysis in Broadwind Energy (BWEN)

• Biotech Resources

  • BIO.com
  • BIO.org
  • BioSpace
  • Centient Biotech Investor
  • Council For Biotech Info
  • EOFHR
  • Nature Biotechnology
  • TR Biotech
  • Yahoo! Finance: Healthcare

• More on Money & Finance

  • AMT
  • Banking
  • Black Friday Deals
  • Credit Cards
  • Credit Reports
  • DailyFinance
  • DJIA
  • Earnings
  • Identity Theft
  • Income Tax Basics
  • Insurance
  • Loans
  • Luxist
  • Market News
  • Money
  • Mortgages
  • Online Tax Filing
  • Recession
  • Retirement
  • Small Business
  • Stock Charts
  • Stock Quotes
  • Stock Ticker
  • Tax Credit
  • Tax Deduction
  • Taxes
  • Walletpop